Skip to content

Comparison of Pediatric Septic Shock Treatment With and Without Central Venous Oxygen Saturation Monitoring

An Outcomes Comparison of ACCM/PALS Guidelines For Pediatric Septic Shock With and Without Central Venous Oxygen Saturation Monitoring

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00407823
Enrollment
268
Registered
2006-12-05
Start date
2004-01-31
Completion date
2005-08-31
Last updated
2006-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock, Severe Sepsis

Keywords

Child, Septic shock, Resuscitation, Central venous oxygen saturation, Cardiac output, Goal-directed therapy

Brief summary

The purpose of this study was to compare ACCM/PALS guidelines performed with and without central venous oxygen saturation monitoring on the morbidity and mortality rate of children with severe sepsis and septic shock.

Detailed description

Background: ACCM/PALS guidelines addresses early correction of pediatric septic shock using physical examination supplemented by indirect measures of cardiac output such as central venous or superior vena cava oxygen saturation (ScvO2\>70%) in a goal directed approach. However, these endpoints are based on unsupported evidence. The purpose of this study was to compare ACCM/PALS guidelines performed with and without ScvO2 on the morbidity and mortality rate of children with severe sepsis and septic shock. Methods: Children and adolescents with severe sepsis or fluid-refractory septic shock were recruited at two university-affiliated hospitals and randomly assigned to ACCM/PALS without, or with an ScvO2 goal directed (goal ScvO2 \> 70%) resuscitation. Twenty-eight day mortality is the primary end point.

Interventions

PROCEDURECentral venous oxygen saturation continuous monitoring

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 19 Years
Healthy volunteers
No

Inclusion criteria

* patients with severe sepsis or fluid-refractory septic shock that had not responded after 40 mL/kg of any resuscitation fluid or that required cardiovascular agents at any time during resuscitation

Exclusion criteria

* refusal to sign the written informed consent * age less than 1 month or older than 19 years * uncorrected cyanotic heart disease * patients receiving exclusive palliative care * patients that arrived from other hospitals more than 6 hours after the diagnosis of severe sepsis or septic shock.

Design outcomes

Primary

MeasureTime frame
28-day mortality

Secondary

MeasureTime frame
Administered treatments
Duration of cardiovascular agents therapy
Duration of mechanical ventilation
Number of organ dysfunction
Days free of cardiovascular agents
Days free of mechanical ventilation
Length of Pediatric Intensive Care Unit stay

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026